Literature DB >> 34092469

Towards equity for people who inject drugs in HIV prevention drug trials.

Jennifer Karen Brody1, Jessica Taylor2, Katie Biello3, Angela R Bazzi4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34092469      PMCID： PMC8568620          DOI： 10.1016/j.drugpo.2021.103284

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN： 0955-3959


× No keyword cloud information.
  3 in total

Review 1.  Management of HCV and HIV infections among people who inject drugs.

Authors:  Jason Grebely; Mark W Tyndall
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

2.  Where Were the Women? Gender Parity in Clinical Trials.

Authors:  Robert H Goldstein; Rochelle P Walensky
Journal:  N Engl J Med       Date:  2019-10-30       Impact factor: 91.245

3.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321
  3 in total
  3 in total

1.  Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California.

Authors:  Angela R Bazzi; Chad J Valasek; Samantha A Streuli; Carlos F Vera; Alicia Harvey-Vera; Morgan M Philbin; Katie B Biello; Alexis M Roth; Steffanie A Strathdee; Heather A Pines
Journal:  AIDS Patient Care STDS       Date:  2022-06-21       Impact factor: 5.944

2.  Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.

Authors:  Angela R Bazzi; Leah C Shaw; Katie B Biello; Seamus Vahey; Jennifer K Brody
Journal:  J Gen Intern Med       Date:  2022-05-25       Impact factor: 6.473

3.  PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV.

Authors:  Kristi C Hill; Sarah M Kattakuzhy; Rachel Silk; Rahwa Eyasu; Onyinyechi Ogbumbadiugha; Emade Ebah; Amelia A Cover; Ashley Davis; Britt Gayle; David Sternberg; Phyllis Bijole; Junfeng Sun; Henry Masur; Shyam Kottilil; Daniel Solomon; Elana S Rosenthal
Journal:  Open Forum Infect Dis       Date:  2022-09-14       Impact factor: 4.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.